Medical network - on April 10, the national development and reform commission YaoXie procurement antitrust swing a punch again, who would have thought that the surveyed was shenzhen health development planning commission, the drug group procurement reform pilot is considered there is violation of the anti-monopoly law.
Development and reform commission (NDRC) of the antitrust investigation was only to drug purchase, however, in February this year, released in 2017 by the shenzhen city health points "family planning work, which clearly put forward, in addition to" continue to promote the reform of public hospital pharmaceutical group purchasing pilot work ", and "explore the reform of medical consumables and medical equipment group purchasing".
Shenzhen was originally to be in the years to explore group procurement of supplies and equipment, and if no accident, consumables and equipment group procurement will also be reference drug. However, along with the development and reform commission (NDRC) antitrust investigations and shenzhen city planning commission's commitment to the rectification, consumables and equipment group purchasing pilot is likely to be delayed. "One enterprise has been the national development and reform commission as illegal monopoly group purchasing service" this matter, certainly also won't appear in the future group of material and equipment procurement in the pilot.
Shenzhen development planning commission of three illegal behavior
On April 7, the national development and reform commission website notice: shenzhen health development planning commission promised to correct in the pilot reform of public hospital drug group procurement abuse administrative power ruled out restrict competition behavior. By the national development and reform commission (NDRC) and the national development and reform commission of guangdong province, shenzhen health development planning commission is the violation of the anti-monopoly law:
1, only allow a group purchasing organization (select medicine network for the whole pharmaceutical industry) with drug group procurement services. Will other capable and willing to provide drug group procurement service operators are excluded, lead to shenzhen public hospital pharmaceutical group procurement market only one operator, there is no competition.
2, limited shenzhen public hospitals, pharmaceutical production enterprise with whole medicine pharmaceutical services provided by the net. Limited shenzhen all public hospitals can only through the whole medicine pharmaceutical procurement net; Disguised qualified drug companies only through the whole medicine network to shenzhen public hospital pharmaceutical drug sales directory, destroyed the drug market competition order.
3, qualified pharmaceutical pharmaceutical designated by the medicine distribution enterprise network. Under the state council general office on perfecting public hospital drug centralized procurement guidelines "(countries do hair [2015] no. 7) about the provisions of the pharmaceutical producing enterprises to choose its own distribution enterprises.
Investigation, shenzhen health development planning commission puts forward three specific measures: one is to allow public hospitals to choose its own procurement platform (all medicine net or provincial procurement platform); Second, the drug companies to choose from distribution enterprises. Three is drug firms to choose its own procurement platform. (see the appendix) in full
Development and reform commission (NDRC) qualitative: hosting is a monopoly
Since August 2016, the whole medicine network won the bid for shenzhen GPO organization, since all the way with controversy. Is corresponding to its price will be reduced by more than 30% commitment, merciless to bargain for domestic drugs, caused panic in the industry, to worry about all kinds of passive prices after the country. And all of these monopoly, make the enterprise is forced to a powerful weapon to pin down.
The national development and reform commission investigation, timely stop shenzhen development planning commission of illegal ACTS. Violation of the anti-monopoly law, however, is widespread in the industry, pharmacy trusteeship is bright.
Reference to practice of shenzhen second "qualified" designated by the whole medicine network pharmaceutical drug distribution enterprises, and the now ubiquitous "public hospital restricted to a single enterprise distribution," both hosted mode, is a property. Fully managed is public hospital of alleged abuse administrative power ruled out restrict competition behavior!
For a monopoly, the national development and reform commission has been in action.
Active pharmaceutical ingredients, fine!
Medical equipment giant medtronic price monopoly, fined 110 million!
This time, for shenzhen health development planning commission, the development and reform commission (NDRC) real-time correction.
So, for the prevalence of pharmacy trusteeship, could it be the national development and reform commission power investigation direction of the next step? And copy the drugs custody mode of consumables, custody and will be targeting?
|
